The power to
COMPARING SCENAR AND TENS
Scenar is a transformative evolution of Tens technology !
SCENAR has built a reputation over decades for effective pain relief, while the TENS machine has been in use for a similar period and is routinely offered as an NHS treatment. Both use electrical impulses to treat pain, but do they differ in performance? Should we be using one over the other to get the results we want?
How bio-electrical pain treatment works
SCENAR (Self-Controlled Energo Neuro Adaptive Regulator) and TENS (Transcutaneous Electrical Nerve Stimulation) therapy both stimulate the body to use its own internal pharmacy to cure a state of damage.
Like the TENS machine, SCENAR is a bio-electrical pain treatment device which transmits signals into the site of a pain or injury. When passed over a painful area, both send out an impulse that is received by the nervous system, and processed by the brain. This stimulates the body’s own repair systems to act, inducing the release of natural painkillers called endorphins.
However, if the signal is repetitive, the body will become desensitised to a particular electrical impulse and eventually ignore it, resulting in the return of the pain.
WHAT MAKES SCENAR SO EFFECTIVE ?
Unlike the TENS machine, SCENAR avoids the problem of desensitisation. The hand held device incorporates a biofeedback mechanism which sets up a two-way communication with the patient’s nervous system. The device reads the returning signal and adjusts its own subsequent impulse parameters so that each new signal differs from the previous one.
This constant change of frequency encourages the body to go on redirecting its activity towards the area of weakness in the body.
Another major distinguishing features of SCENAR therapy is that it inﬂuences local blood ﬂow, especially micro-circulation, which is important in the treatment of sports injuries. Blood delivers the basic building blocks to repair cells and removes dead tissue and waste products from the affected site.
The result is that pain relief may be permanent, or at least extend for increasingly longer periods between with each treatment.
Neuropeptides: SCENAR therapy is also effective at inducing neuropeptide release by the body, which promotes pain reduction and repair for a wide array of complaints and conditions.
Neuropeptides are a group of protein-like compounds that act as neurotransmitters, regulating almost all life processes at the cellular level and linking together body systems. Among other regulatory functions, neuropeptides are important in reducing inﬂammation. They are naturally occurring molecules that are non-invasive, non-addictive, acting efficiently in the body without adverse side effects.
Request a callback to discuss training and devices for enhancing your practice
SCENAR v TENS: CLINICAL TRIAL
Chronic neck pain is difficult to diagnose and treat, being resistant to common therapeutic interventions. Therefore, a study was carried out in Australia in 2006-7 to see if there were significant differences in performance between SCENAR and TENS.
A group of 24 people between the ages of 18 and 50 suffering from non-complicated chronic neck pain (NCCNP) were split into three groups; one group received SCENAR treatment, another was treated with a TENS device and the third group received a control procedure.
All groups were given twelve 15-minute treatment sessions over a six week period. Results were measured throughout the treatment period, at the 0, 6, 12, 18 and 24 week points, using acknowledged pain and functionality assessment scales.
The SCENAR group showed a marked decrease in mean pain scores from time zero to the first follow-up measurement, six weeks into the trial and this improvement was maintained until week 24. However, the TENS and control groups showed similar and consistent pain levels throughout the trial.
A follow-up assessment after six months also showed that pain and neck disability levels within the SCENAR group were around half that of either the TENS or the control.
Scenar is the hands-down winner
The study concluded that the SCENAR therapy participants reported a significant reduction in the intensity of neck pain and disability as well as an increased functionality compared to the TENS or control participants, not just throughout the treatment phase but well afterwards.
The study and its results have been registered with the Australian Clinical Trials Registry (ACTR).
Although TENS therapy has provided short-term pain relief over the years, pain only subsides while the TENS unit is activated, and this effect decreases with use due to desensitisation.
In contrast, SCENAR therapy, which was developed for use on the USSR’s space programme, is a technological quantum leap ahead of TENS therapy. It’s unique biofeedback system ‘listens’ and responds to the body, resulting in a more profound and long lasting healing response.
The answer to the question “which device is most effective for pain management” is undoubtedly SCENAR.
What our Users are saying
Don't just take our word for it
My first experience of Scenar was in 2000 post the RWC where I sustained a groin injury after 7 months of traditional physio treatment and limited succès I was introduced to Scenar by my then fitness coach Margot Wells. Within 2 weeks I was back to full training and within 4 was back to playing… Read more “Dan Luger – England International Rugby Player”
I fell heavily onto my left hand, twisting the thumb at a right angle. This left major bruising and swelling in the thumb, wrist and hand, and significant pain, especially at night. With professional SCENAR treatment, I was surprised to see the bruising and swelling reduce in even the first treatment, and after several treatments,… Read more “Mary Jensen”